Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74
polypeptides
    41.
    发明授权
    Polynucleotides encoding G-protein parathyroid hormone receptor HLTDG74 polypeptides 失效
    编码G蛋白甲状旁腺激素受体HLTDG74多肽的多核苷酸

    公开(公告)号:US6030804A

    公开(公告)日:2000-02-29

    申请号:US468011

    申请日:1995-06-06

    摘要: Human G-protein parathyroid hormone (PTH) receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the PTH receptor receptor polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the PTH receptor receptor nucleic acid sequences and detecting a level of the soluble form of the receptors in a sample derived from a host.

    摘要翻译: 公开了人类G蛋白甲状旁腺激素(PTH)受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及在治疗上使用激动剂和拮抗剂治疗与PTH受体受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测PTH受体受体核酸序列中的突变并检测衍生自宿主的样品中受体的可溶形式水平的诊断方法。

    Human G-Protein Receptor HGBER32
    43.
    发明申请
    Human G-Protein Receptor HGBER32 审中-公开
    人类G蛋白受体HGBER32

    公开(公告)号:US20080312178A1

    公开(公告)日:2008-12-18

    申请号:US12182466

    申请日:2008-07-30

    摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed were methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.

    摘要翻译: 公开了人G-蛋白偶联受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体的可溶形式的改变水平的诊断方法。

    Antibodies that bind human prostate specific G-protein receptor HPRAJ70
    44.
    发明授权
    Antibodies that bind human prostate specific G-protein receptor HPRAJ70 失效
    结合人前列腺特异性G蛋白受体HPRAJ70的抗体

    公开(公告)号:US06824993B2

    公开(公告)日:2004-11-30

    申请号:US09968033

    申请日:2001-10-02

    IPC分类号: C07K1618

    摘要: The present invention relates to PSGR, a novel prostate specific gene with homology to a G-protein coupled receptor overexpressed in prostate cancer. More specifically, the invention relates to PSGR polynucleotides and the polypeptides encoded by these polynucleotides, and the use of PSGR polynucleotides and polypeptides for detecting disorders of the reproductive system, including disorders of the prostate, particularly the presence of cancer. This invention relates to PSGR polynucleotides and polypeptides as well as vectors, host cells, antibodies directed to PSGR polynucleotides and polypeptides and recombinant and synthetic methods for producing the same. Also provided are methods for diagnosing, treating, preventing, and/or prognosing disorders related to the prostate, including cancer. The invention further relates to screening methods for identifying agonists and antagonists of PSGR polynucleotides and polypeptides of the invention and methods and/or compositions for inhibiting or enhancing the production and/or function of the PSGR polypeptides of the present invention.

    摘要翻译: 本发明涉及PSGR,一种与在前列腺癌中过表达的G蛋白偶联受体具有同源性的新型前列腺特异性基因。 更具体地,本发明涉及PSGR多核苷酸和由这些多核苷酸编码的多肽,以及使用PSGR多核苷酸和多肽来检测生殖系统疾病,包括前列腺疾病,特别是癌症的存在。 本发明涉及PSGR多核苷酸和多肽以及载体,宿主细胞,针对PSGR多核苷酸和多肽的抗体以及用于制备它的重组和合成方法。 还提供了用于诊断,治疗,预防和/或预后与前列腺相关的疾病(包括癌症)的方法。 本发明还涉及用于鉴定本发明的PSGR多核苷酸和多肽的激动剂和拮抗剂的筛选方法以及用于抑制或增强本发明的PSGR多肽的产生和/或功能的方法和/或组合物。

    Human G-protein receptor HPRAJ70
    45.
    发明授权

    公开(公告)号:US5948890A

    公开(公告)日:1999-09-07

    申请号:US53303

    申请日:1998-04-01

    IPC分类号: C07K14/705 C07K16/28

    CPC分类号: C07K16/28 A61K2039/505

    摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed were methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.

    Human G-Protein Coupled Receptor (HETGQ23)
    46.
    发明申请
    Human G-Protein Coupled Receptor (HETGQ23) 审中-公开
    人类G蛋白偶联受体(HETGQ23)

    公开(公告)号:US20110112177A1

    公开(公告)日:2011-05-12

    申请号:US12943202

    申请日:2010-11-10

    CPC分类号: C07K14/705

    摘要: Human G-protein coupled receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed were methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein coupled receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein coupled receptor nucleic acid sequences and an altered level of the soluble form of the receptors.

    摘要翻译: 公开了人G-蛋白偶联受体多肽和编码此类多肽的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这些多肽来鉴定此类多肽的拮抗剂和激动剂的方法,以及分别在治疗上使用激动剂和拮抗剂治疗与G蛋白偶联受体多肽的低表达和过表达相关的病症的方法。 还公开了用于检测G蛋白偶联受体核酸序列中的突变和受体的可溶形式的改变水平的诊断方法。

    Human Nodal and Lefty Homologues
    48.
    发明申请
    Human Nodal and Lefty Homologues 审中-公开
    人类节点和遗传同源物

    公开(公告)号:US20080242604A1

    公开(公告)日:2008-10-02

    申请号:US11466004

    申请日:2006-08-21

    摘要: The present invention relates to novel Nodal and Lefty proteins which are members of the TGF-β family. In particular, isolated nucleic acid molecules are provided encoding the human Nodal and Lefty proteins. Nodal and Lefty polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of Nodal and Lefty activity. Also provided are diagnostic methods for detecting cell growth and differentiation-related disorders and therapeutic methods for treating cell growth and differentiation-related disorders.

    摘要翻译: 本发明涉及作为TGF-β家族成员的新型Nodal和Lefty蛋白。 特别地,提供了分离的核酸分子,其编码人淋巴结和Lefty蛋白质。 还提供了Nodal和Lefty多肽,载体,宿主细胞以及用于制备它们的重组方法。 本发明还涉及用于鉴定淋巴结和Lefty活性的激动剂和拮抗剂的筛选方法。 还提供了用于检测细胞生长和分化相关疾病的诊断方法以及用于治疗细胞生长和分化相关疾病的治疗方法。

    Peptidoglycan recognition proteins
    49.
    发明授权
    Peptidoglycan recognition proteins 失效
    肽聚糖识别蛋白

    公开(公告)号:US07368244B2

    公开(公告)日:2008-05-06

    申请号:US11214796

    申请日:2005-08-31

    IPC分类号: C07H21/00

    CPC分类号: C07K14/47 A61K38/00

    摘要: The present invention related to three novel peptidoglican recognition binding protein expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A-B, FIGS. 2A-C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-c polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.

    摘要翻译: 本发明涉及由角质形成细胞,伤口愈合组织和软骨肉瘤组织表达的三种新型肽基识别结合蛋白。 更具体地,提供分离的核酸分子,其编码人胶原聚糖识别蛋白相关蛋白(本文称为PGRP-K(角质形成细胞),PGRP-W(伤口愈合)和PGRP-C(软骨肉瘤))。 图1A-B, 图2A-C, 3,分别与人肽聚糖识别蛋白(PGRP)以及鼠Tag-7都具有同源性。 还提供了PGRP-K,PGRP-W和PGRP-C多肽。 进一步提供载体,宿主细胞和用于制备其的重组方法。 本发明还涉及PGRP-K,PGRP-W和PGRP-c多肽的活性的抑制和增强以及用于检测PGRP-K,PGRP-W和PGRP-C基因表达的诊断方法。

    Peptidoglycan recognition proteins
    50.
    发明授权
    Peptidoglycan recognition proteins 失效
    肽聚糖识别蛋白

    公开(公告)号:US07041802B2

    公开(公告)日:2006-05-09

    申请号:US10180454

    申请日:2002-06-27

    CPC分类号: C07K14/47 A61K38/00

    摘要: The present invention relates to three novel peptidoglycan recognition binding proteins expressed by keratinocytes, wound-healing tissues and chondrosarcoma tissue. More specifically, isolated nucleic acid molecules are provided encoding human peptidoglycan recognition protein-related proteins, referred to herein as PGRP-K (Keratinocytes), PGRP-W (Wound-healing), and PGRP-C (Chondrosarcoma) of FIGS. 1A–B, FIGS. 2A–C, and FIG. 3, respectively, each having homology to both human peptidoglycan recognition protein (PGRP) as well as murine Tag-7. PGRP-K, PGRP-W, and PGRP-C polypeptides are also provided. Further provided are vectors, host cells and recombinant methods for producing the same. The invention also relates to both the inhibition and enhancement of activities of PGRP-K, PGRP-W, and PGRP-c polypeptides and diagnostic methods for detecting PGRP-K, PGRP-W, and PGRP-C gene expression.

    摘要翻译: 本发明涉及由角质形成细胞,伤口愈合组织和软骨肉瘤组织表达的三种新的肽聚糖识别结合蛋白。 更具体地,提供分离的核酸分子,其编码人胶原聚糖识别蛋白相关蛋白(本文称为PGRP-K(角质形成细胞),PGRP-W(伤口愈合)和PGRP-C(软骨肉瘤))。 图1A-B, 图2A-C, 3,分别与人肽聚糖识别蛋白(PGRP)以及鼠Tag-7都具有同源性。 还提供了PGRP-K,PGRP-W和PGRP-C多肽。 进一步提供载体,宿主细胞和用于制备其的重组方法。 本发明还涉及PGRP-K,PGRP-W和PGRP-c多肽的活性的抑制和增强以及用于检测PGRP-K,PGRP-W和PGRP-C基因表达的诊断方法。